VYNE vs CLYM

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Aug 04, 2026

VYNE

39.7
AI Score
VS
CLYM Wins

CLYM

55.6
AI Score

Investment Advisor Scores

VYNE

40score
Recommendation
SELL

CLYM

56score
Recommendation
HOLD

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric VYNE CLYM Winner
Net Income -26.48M -13.72M CLYM
Operating Income -29.75M -15.21M CLYM
ROE -95.4% -9.3% CLYM
ROA -87.8% -9.0% CLYM
Total Assets 30.16M 152.37M CLYM
Cash 24.03M 8.36M VYNE
Current Ratio 12.53 27.86 CLYM

Relative Price Performance (Last 90 Days)

VYNE 1M: +4282.4% · 3M: +4327.2% CLYM 1M: -8.4% · 3M: +32.5%

Current Technical Phase

VYNE

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (89.2% over 20 days), RSI 99

RSI (14): 98.5 · Price: $28.56

CLYM

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 42

RSI (14): 42.2 · Price: $11.81

Fundamentals Snapshot

Metric VYNE CLYM
Market Cap
Forward P/E -0.4 -10.4
Trailing P/E
Revenue (TTM)
Revenue Growth -0.6% 0.0%
Gross Margin 1.0%
Operating Margin -44.4% 0.0%
EPS -25.50 -0.77
Dividend Yield 0.00%

Frequently Asked Questions

Based on our detailed analysis, CLYM is currently the stronger investment candidate, winning 6 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.